Literature DB >> 32299582

Amyloid: From Starch to Finish.

Hannah L Krystal1, David A Ross2, Adam P Mecca2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32299582      PMCID： PMC7449531          DOI： 10.1016/j.biopsych.2020.02.1182

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  9 in total

1.  Amyloidosis: a convoluted story.

Authors:  R A Kyle
Journal:  Br J Haematol       Date:  2001-09       Impact factor: 6.998

Review 2.  The intersection of amyloid beta and tau at synapses in Alzheimer's disease.

Authors:  Tara L Spires-Jones; Bradley T Hyman
Journal:  Neuron       Date:  2014-05-21       Impact factor: 17.173

3.  Auguste D and Alzheimer's disease.

Authors:  K Maurer; S Volk; H Gerbaldo
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

Review 4.  The activities of amyloids from a structural perspective.

Authors:  Roland Riek; David S Eisenberg
Journal:  Nature       Date:  2016-11-10       Impact factor: 49.962

Review 5.  Autophagy Dysfunction in Alzheimer's Disease: Mechanistic Insights and New Therapeutic Opportunities.

Authors:  Antonio Di Meco; Mary Elizabeth Curtis; Elisabetta Lauretti; Domenico Praticò
Journal:  Biol Psychiatry       Date:  2019-05-20       Impact factor: 13.382

Review 6.  [Post-mortem diagnosis of Alzheimer's disease].

Authors:  D R Thal; H Braak
Journal:  Pathologe       Date:  2005-05       Impact factor: 1.011

Review 7.  Tau-targeting therapies for Alzheimer disease.

Authors:  Erin E Congdon; Einar M Sigurdsson
Journal:  Nat Rev Neurol       Date:  2018-07       Impact factor: 42.937

8.  Alzheimer's-like pathology in aging rhesus macaques: Unique opportunity to study the etiology and treatment of Alzheimer's disease.

Authors:  Amy F T Arnsten; Dibyadeep Datta; Shannon Leslie; Sheng-Tao Yang; Min Wang; Angus C Nairn
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

Review 9.  Anti-Amyloid-β Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise.

Authors:  Christopher H van Dyck
Journal:  Biol Psychiatry       Date:  2017-08-24       Impact factor: 13.382
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.